Abstract:Background. Microarray technology enables a standardized, objective assessment of oncological diagnosis and prognosis. However, such studies are typically specific to certain cancer types, and the results have limited use due to inadequate validation in large patient cohorts. Discovery of genes commonly regulated in cancer may have an important implication in understanding the common molecular mechanism of cancer. Methods and Findings. We described an integrated gene-expression analysis of 2,186 samples from 39 studies to identify and validate a cancer type-independent gene signature that can identify cancer patients for a wide variety of human malignancies. The commonness of gene expression in 20 types of common cancer was assessed in 20 training datasets. The discriminative power of a signature defined by these common cancer genes was evaluated in the other 19 independent datasets including novel cancer types. QRT-PCR and tissue microarray were used to validate commonly regulated genes in multiple cancer types. We identified 187 genes dysregulated in nearly all cancerous tissue samples. The 187-gene signature can robustly predict cancer versus normal status for a wide variety of human malignancies with an overall accuracy of 92.6%. We further refined our signature to 28 genes confirmed by QRT-PCR. The refined signature still achieved 80% accuracy of classifying samples from mixed cancer types. This signature performs well in the prediction of novel cancer types that were not represented in training datasets. We also identified three biological pathways including glycolysis, cell cycle checkpoint II and plk3 pathways in which most genes are systematically up-regulated in many types of cancer. Conclusions. The identified signature has captured essential transcriptional features of neoplastic transformation and progression in general. These findings will help to elucidate the common molecular mechanism of cancer, and provide new insights into cancer diagnostics, prognostics and therapy.

[Identification of Gene Functional Modules Shared by Cancers Based on Biclustering].

Peeling Off the Hidden Genetic Heterogeneities of Cancers Based on Disease-Relevant Functional Modules

Common Human Cancer Genes Discovered by Integrated Gene-Expression Analysis

Identification of Cancer Trait Genes and Association Analysis under Pan-Cancer

A Cancer Gene Module Mining Method Based on Bio-Network of Multi-Omics Gene Groups

Discovering Distinct Functional Modules of Specific Cancer Types Using Protein-Protein Interaction Networks

Evolutionary Mechanism Based Conserved Gene Expression Biclustering Module Analysis for Breast Cancer Genomics

The Detection of Gene Modules with Overlapping Characteristic via Integrating Multi-omics Data in Six Cancers

Identification of cancer prognosis-associated functional modules using differential co-expression networks.

Application of Betweenness Clustering Algorithm in Cancer Gene Expression Profiles

Comprehensive Analysis of Differential Gene Expression to Identify Common Gene Signatures in Multiple Cancers

BiModule: Biclique Modularity Strategy for Identifying Transcription Factor and Microrna Co-Regulatory Modules

Discovery of Pan-Cancer Related Genes Via Integrative Network Analysis.

Identifying Cancer Prognostic Modules by Module Network Analysis

Identification of Common Driver Gene Modules and Associations between Cancers through Integrated Network Analysis

Exploring Gene-Mediated Mechanisms Behind Shared Phenotypes Across Diverse Diseases Using the clGENE Tool

Identification of breast cancer risk modules via an integrated strategy

Cancer Core Modules Identification Through Genomic and Transcriptomic Changes Correlation Detection at Network Level.

Identification of core genes and potential molecular mechanisms in breast cancer using bioinformatics analysis

Identification of Cancer Hallmarks Based on the Gene Co-expression Networks of Seven Cancers

Integration of multi-omics data to mine cancer-related gene modules